Robeco Institutional Asset Management B.V. Sells 507,124 Shares of Zoetis Inc. $ZTS

Robeco Institutional Asset Management B.V. cut its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 93.0% during the third quarter, Holdings Channel.com reports. The firm owned 38,324 shares of the company’s stock after selling 507,124 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Zoetis were worth $5,608,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Nova Wealth Management Inc. bought a new stake in shares of Zoetis in the 1st quarter valued at about $25,000. Halbert Hargrove Global Advisors LLC grew its holdings in shares of Zoetis by 496.6% during the third quarter. Halbert Hargrove Global Advisors LLC now owns 173 shares of the company’s stock valued at $25,000 after buying an additional 144 shares during the last quarter. REAP Financial Group LLC increased its holdings in shares of Zoetis by 201.5% in the second quarter. REAP Financial Group LLC now owns 196 shares of the company’s stock valued at $31,000 after purchasing an additional 131 shares during the period. NewSquare Capital LLC increased its holdings in Zoetis by 69.1% in the 2nd quarter. NewSquare Capital LLC now owns 208 shares of the company’s stock worth $32,000 after buying an additional 85 shares during the period. Finally, 1248 Management LLC acquired a new stake in shares of Zoetis in the first quarter worth $35,000. Institutional investors own 92.80% of the company’s stock.

Analysts Set New Price Targets

ZTS has been the subject of several analyst reports. UBS Group decreased their price objective on Zoetis from $158.00 to $141.00 and set a “neutral” rating for the company in a report on Wednesday, November 5th. KeyCorp began coverage on Zoetis in a research report on Thursday, November 20th. They set a “sector weight” rating for the company. Stifel Nicolaus lowered their price objective on Zoetis from $140.00 to $130.00 and set a “hold” rating on the stock in a research report on Tuesday, November 18th. HSBC set a $140.00 target price on shares of Zoetis in a report on Wednesday, December 10th. Finally, BTIG Research reissued a “buy” rating and set a $160.00 price target on shares of Zoetis in a report on Wednesday, December 3rd. Six analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $160.18.

Zoetis Price Performance

Zoetis stock opened at $127.10 on Friday. The stock has a market capitalization of $56.01 billion, a P/E ratio of 21.40, a P/E/G ratio of 2.59 and a beta of 0.97. The company’s fifty day moving average price is $123.29 and its 200 day moving average price is $140.60. The company has a debt-to-equity ratio of 1.31, a quick ratio of 2.28 and a current ratio of 3.64. Zoetis Inc. has a 1 year low of $115.25 and a 1 year high of $177.40.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Tuesday, November 4th. The company reported $1.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.08. Zoetis had a net margin of 28.21% and a return on equity of 57.19%. The business had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.42 billion. During the same period last year, the firm posted $1.58 earnings per share. The company’s revenue was up .5% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, equities research analysts anticipate that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 3rd. Investors of record on Tuesday, January 20th will be paid a $0.53 dividend. The ex-dividend date of this dividend is Tuesday, January 20th. This represents a $2.12 dividend on an annualized basis and a yield of 1.7%. This is a boost from Zoetis’s previous quarterly dividend of $0.50. Zoetis’s dividend payout ratio is 33.67%.

Zoetis Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.